PMC4342861_01
A well-defined nodule (4.0 x 3.8 cm) of HCC in S5 of the liver (case 1). a Before it ruptured (arrow). b After it ruptured and embolized (arrow).
crg-0009-0029-g01.jpg
PMC4342861_01_crg-0009-0029-g01.jpg
F1
In 2008, he was diagnosed with three nodules of HCC in S4 and S5, the largest being 35 mm in diameter (fig. 1a). TAE for hemostasis (fig. 1b). He underwent LDLT 3 months after the episode of ruptured HCC (fig. 2a, b), with a Child-Turcotte-Pugh (CTP) class of C (10 points), a model of end-stage liver disease (MELD) score of 10 points, and also had HCC within the Milan criteria (fig. 2c, d).
a No peritoneal dissemination at laparotomy. b Left lobe graft. c Explanted liver with HCC (arrow). d Cross-section of explanted liver with HCC (arrow).
crg-0009-0029-g02.jpg
PMC4342861_01_crg-0009-0029-g02.jpg
F2
TAE for hemostasis (fig. 1b). He underwent LDLT 3 months after the episode of ruptured HCC (fig. 2a, b), with a Child-Turcotte-Pugh (CTP) class of C (10 points), a model of end-stage liver disease (MELD) score of 10 points, and also had HCC within the Milan criteria (fig. 2c, d).
The peritoneal recurrence (5.6 x 5.3 cm) found by a CT scan (case 1).
crg-0009-0029-g03.jpg
PMC4342861_01_crg-0009-0029-g03.jpg
F3
Peritoneal dissemination was diagnosed in this patient 32 months after LDLT (fig. 3).
PMC4342861_02